SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01096654

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01096654
Other papers using this trial's data
  • Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial The lancet. Diabetes & endocrinology, 2016-09 DOI, PubMed 27325147
  • Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment The Journal of clinical endocrinology and metabolism, 2018-01-01 DOI, PubMed 29099925

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01096654. Randomized; no masking; primary purpose diagnostic. Start 2010-07 (registry gives no type); primary completion 2015-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan.
Acronym
SPARTACUS
Condition
Hyperaldosteronism
Intervention (Other)
Ct-scan or adrenal vein sampling
Lead sponsor
Radboud University Medical Center (class: other)

Record details

Record id
cardio:ct-nct01096654
Content hash
d63bb65f8368a3bb8916a1f5befbb522652328c5128f59aa166788209fd77c48